The change in serum Ca 19-9 levels according to treatment responses in pulmonary nontuberculous mycobacterial disease Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015
Correlation between matrix metalloproteinase-9 serum levels and disease severity in pulmonary tuberculosis patients Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Differential microRNA expression in plasma of patients with pulmonary tuberculosis Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015
Verification of pulmonary tuberculosis in HIV-infected patients with low CD4 Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014
Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014
Blood and urine IP-10 associate with active TB in HIV-infected patients Source: International Congress 2016 – Latent tuberculosis infection Year: 2016
Late Breaking Abstract - Correlation of sputum microRNA-144 expression levels with treatment response among pulmonary tuberculosis patients Source: International Congress 2018 – New developments in tuberculosis Year: 2018
Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients Source: International Congress 2015 – Screening strategies in TB Year: 2015
Clinicoradiological features of pulmonary tuberculosis associated with interstitial pneumonia Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Lymphocytopenia in pulmonary tuberculosis: Does it have a clinical value? Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Study of inflammatory markers in sputum positive patients of pulmonary tuberculosis and its response to anti-tubercular treatment Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Changes in pulmonary function in patients with lung tuberculoma Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Species differences in NTM pulmonary disease (pNTM) Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Ca 19-9 serum levels in patients with end-stage Idiopathic Pulmonary Fibrosis (IPF) Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with BA Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
Active tuberculosis prevalence and characteristics of tuberculosis patients in liver transplant patients Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015
Association of serum cytokines with pulmonary tuberculosis treatment outcomes Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
Pulmonary tuberculosis (TB) as a complication of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009
C-reactive protein and pulmonary tuberculosis: What correlation with disease severity Source: International Congress 2015 – Management of TB: a patient focus Year: 2015